Double-edged sword behaviour of gallic acid and its interaction with peroxidases in human microvascular endothelial cell culture (HMEC-1). Antioxidant and pro-oxidant effects

Acta Biochimica Polonica

Volumn 57, Issue 2, 2010, Pages 193-198

  Serrano, José ^a   Cipak, Ana ^b   Boada, Jordi ^a   Gonzalo, Hugo ^a   Cacabelos, Daniel ^a   Cassanye, Anna ^a   Pamplona, Reinald ^a   Zarkovic, Neven ^b   Portero Otin, Manuel ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

^b RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

Antioxidant; Gallic acid; HMEC 1; Peroxidase; Pro oxidant

Indexed keywords

EID: 77956550875     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2010_2394     Document Type: Article

References (21)

1. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683-690.
2. Cully M, Downward J (2009) Translational responses to growth factors and stress. Biochem Soc Trans 37: 284-288.
3. Daugherty A, Dunn JL, Rateri DL, Heinecke JW (1994) Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J Clin Invest 94: 437-444.
4. Grassi D, Desideri G, Croce G, Tiberti S, Aggio A, Ferri C (2009) Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des 15: 1072-1084.
5. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H (2003) Role of oxidative stress in atherosclerosis. Am J Cardiol 91: 7A-11A.
6. Heinecke JW (2003) Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 91: 12A-16A.
7. Hu FB (2009) Diet and lifestyle influences on risk of coronary heart disease. Curr Atheroscler Rep 11: 257-263.
8. Kato Y, Nagao A, Terao J, Osawa T (2003) Inhibition of myeloperoxidase-catalyzed tyrosylation by phenolic antioxidants in vitro. Bioscience, Biotechnol Biochem 67: 1136-1139.
9. Lee JR, Kim JK, Lee SJ, Kim KP (2009) Role of protein tyrosine nitration in neurodegenerative diseases and atherosclerosis. Arch Pharm Res 32: 1109-1118.
10. Manach C, Williamson G, Morand C, Scalbert A, Re'me'sy C (2005) Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr 81: 230S-242S.
11. Martindale JL, Holbrook NJ (2002) Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 192: 1-15.
12. Mocatta TJ, Pilbrow AP, Cameron VA, Senthilmohan R, Frampton CM, Richards AM, Winterbourn CC (2007) Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction. J Am Coll Cardiol 49: 1993-2000.
13. Papadopoulus NG, Dedoussis GVZ, Spanakos, Gritzapis AD, Bazevanis CN, Papamichail M (1994) An improved fluorescence assay for the determination of lymphocyte cytotoxicity using flow cytometry. J Immunol Methods 177: 101-111.
14. Pincemail J, Deby C, Thirion A, de Bruyn-Dister M, Goutier R (1988) Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds. Experientia 44: 450-453.
15. Rosso R, Vieira TO, Leal PC, Nunes RJ, Yunes RA, Creczynski-Pasa TB (2006) Relationship between the lipophilicity of gallic acid n-alquil esters' derivatives and both myeloperoxidase activity and HOCl scavenging. Bioorg Med Chem 14: 6409-6413.
16. Roy H, Bhardwaj S, Yla-Herttuala S (2009) Molecular genetics of atherosclerosis. Hum Genet 125: 467-491.
17. Schindhelm RK, Van Der Zwan LP, Teerlink T, Scheffer PG (2009) Myeloperoxidase: A useful biomarker for cardiovascular disease risk stratification? Clin Chem 55: 1462-1470
18. Serrano J, Jové M, Boada J, Bellmunt MJ, Pamplona R, Portero-Otín M (2009) Dietary antioxidants interfere with Amplex Red-coupledfluorescence assays. Biochem Biophys Res Commun 388: 443-449.
19. Shiba Y, Kinoshita T, Chuman H, Taketani Y, Eiji Takeda, Kato Y, Naito M, Kawabata K, Ishisaka A, Terao A, Kawai Y (2008) Flavonoids as substrates and inhibitors of myeloperoxidase: molecular actions of aglycone and metabolites. Chem Res Toxicol 21: 1600-1609.
20. Witting P, Pettersson K, Östlund-Lindqvist A, Westerlund C, Wågberg M, Stocker R (1999) Dissociation of atherogenesis from aortic accumulation of lipid hydro(pero)xides in watanabe heritable hyperlipidemic rabbits. J Clin Invest 104: 213-220.
21. Yokoyama M (2004) Oxidant stress and atherosclerosis. Curr Opin Pharmacol 4: 110-115.